Foresite Capital Management II, LLC insider trades: 10x Genomics (TXG) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Foresite Capital Management II, LLC reports to the SEC
Open-market buys and sales
15 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 13, 2020 | TXG | ↓ Sell | 1,450,000 | $80.13 | $116.2M | Indirect | May 14, 2020 (1d) |
| Mar 17, 2020 | TXG | ↓ Sell | 750,000 | $59.00 | $44.3M | Indirect | Mar 19, 2020 (2d) |
| Feb 27, 2020 | AERI | ↓ Sell | 1,000,000 | $17.07 | $17.1M | Indirect | Mar 2, 2020 (4d) |
| Sep 12, 2019 | TXG | ↑ Buy | 187,500 | $39.00 | $7.3M | Indirect | Sep 16, 2019 (4d) |
| Sep 5, 2019 | AERI | ↑ Buy | 115,900 | $18.47 | $2.1M | Indirect | Sep 6, 2019 (1d) |
| Sep 3, 2019 | AERI | ↑ Buy | 75,000 | $21.00 | $1.6M | Indirect | Sep 4, 2019 (1d) |
| Aug 23, 2019 | AERI | ↑ Buy | 46,153 | $23.45 | $1.1M | Indirect | Aug 23, 2019 (0d) |
| Aug 20, 2019 | AERI | ↑ Buy | 153,847 | $23.88 | $3.7M | Indirect | Aug 20, 2019 (0d) |
| Aug 14, 2019 | AERI | ↑ Buy | 539,555 | $24.73 | $13.3M | Indirect | Aug 14, 2019 (0d) |
| May 26, 2017 | AERI | ↓ Sell | 20,000 | $55.95 | $1.1M | Indirect | May 31, 2017 (5d) |
| Oct 6, 2016 | AERI | ↓ Sell | 50,000 | $40.34 | $2.0M | Indirect | Oct 7, 2016 (1d) |
| Jul 22, 2016 | AERI | ↑ Buy | 250,000 | $17.50 | $4.4M | Indirect | Jul 26, 2016 (4d) |
| May 31, 2016 | AIMT | ↓ Sell | 240,000 | $15.23 | $3.7M | Indirect | Jun 2, 2016 (2d) |
| Aug 24, 2015 | AIMT | ↑ Buy | 25,485 | $19.65 | $501K | Indirect | Aug 26, 2015 (2d) |
| Aug 11, 2015 | AIMT | ↑ Buy | 642,035 | $16.12 | $10.3M | Indirect | Aug 11, 2015 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TXG insiders
Open-market trades in the last 12 months
About Foresite Capital Management II, LLC's insider trades
Foresite Capital Management II, LLC is a 10% owner of 10x Genomics (TXG). Since Aug 11, 2015, it has reported 9 open-market purchases worth $44.4M and 6 sales worth $184.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (8 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TXG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.